Objective: Indirect acute lung injury is associated with high morbidity and mortality. However, the underlying pathophysiology is only marginally understood, and so far no pathophysiologicbased remedy exists. We hypothesized that apoptosis of lung epithelial cells is a pathophysiological relevant process in the development of indirect acute lung injury and that it should be accessible to a siRNA-based therapeutic intervention in vivo.
T he incidences of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) in the United States have been reported to be 79 and 59 per 100,000 persons per year, respectively (1) (2) (3) . Approximately 7% of intensive care patients will eventually have ALI/ARDS develop (4, 5) . The development of ALI in critically ill trauma patients contributes independently to in-hospital mortality (6) . Studies suggest a lethality of 40% for ALI or ARDS (1, 2) , and the presence of sepsis represents one of the highest risk factors for mortality from ARDS (up to 50%) (4, 7, 8) . Despite these unfortunate statistics, therapeutic strategies for the treatment of ALI are still very limited and not pathophysiologically oriented. So far, lung-protective ventilatory regimens (9) and intermittent prone positioning (2) are the only therapeutic options with proven efficacy.
Apoptosis represents an energy-consuming, organized way of cell death. The extrinsic apoptotic pathway is triggered through the death receptors, including Fas (CD95), whereas the intrinsic mitochondrial pathway is activated by diverse stimuli such as reactive oxygen species, radiation, and chemotherapeutic agents. Both pathways ultimately cleave caspase-3 and activated endonucleases, which then induce the cleavage of the DNA and the death of the cell (10) . In this regard, we have previously reported that activation of the FasL-Fas pathway in lung epithelial cells appears to be involved in the pathogenesis of indirect septic ALI (11, 12) . Activation of Fas in the early phase of ALI appears to trigger pulmonary apoptosis and lung inflamma-tion, and thus it may represent mechanisms linking neutrophil recruitment and lung apoptosis (13) . However, to this end, it remains unclear which role lung apoptosis itself plays in the development of septic ALI and whether this potential pathomechanism is accessible to therapeutic intervention.
We sought to investigate whether lung epithelial cell apoptosis was a crucial mechanism in the pathogenesis of shockinduced septic ALI and whether it was accessible to therapeutic intervention using a clinically relevant, double-hit, animal model of hemorrhagic shock followed by polymicrobial sepsis. We tested the hypothesis that local tissue silencing of the central executioner caspase-3, by means of doublestranded siRNAs against caspase-3 messenger RNA, in the lung after shock ameliorated septic ALI and beneficially affected survival. were assembled, de-protected, duplexed, and desalted by Dharmacon (Lafayette, CO). The following sequences were tested in vitro: caspase-3 duplex 1, sense: 5Ј-CAACGGAAUUC-GAGUCCUUUU-3Ј, antisense: 5Ј-AAGGACUC-GAAUUCCGUUGUU-3Ј; caspase-3 duplex 2, sense: 5Ј-GGAUAGUGUUUCUAAGGAAUU-3Ј, antisense: 5Ј-UUCCUUAGAAACACUAUCCUU-3Ј; caspase-3 duplex 3, sense: 5Ј-GCACUG-GAAUGUCAUCUCGUU-3Ј; antisense: 5Ј-CGAGAUGACAUUCCAGUGCUU-3Ј; caspase-3 duplex 4, sense: 5Ј-CGCACAAGCUAGAAU-UUAUUU-3Ј, antisense: 5Ј-AUAAAUUCUAGCU-UGUGCGUU-3Ј; and control GFP-siRNA, sense: 5Ј-GGCUACGUCCAGGAGCGCACCUU-3Ј, antisense sequence: 5Ј-UGCGCUCCUGGACGUAGC-CUU-3Ј.
Transfection of siRNA In Vitro
The mouse macrophage cell line, RAW 264.7 (American Type Culture Collection, Manassas, VA) was grown in Falcon tissue culture flasks (Becton Dickinson, Franklin Lakes, NY) until approximately 50%. Cells were resuspended in 5 mL DMEM (including 10% fetal calf serum, 1% 100ϫ HEPES, but no Gentamicin). Cells were divided into 2-mL tubes (Eppendorf) at a concentration of 6 ϫ 10 6 cells/tube, centrifuged, and were then resuspended in 100 L Nucleofactor solution V (Amaxa, Gaithersburg, MD) containing either 300 pmol caspase-3 silencing RNA sequences or GFP-siRNA serving as a control. Transfection protocol T-24 (Nucleofector; Amaxa) was chosen because it was found to provide excellent transfection results (Ͼ90%) as determined using a Cy5-tagged-siRNA-sequence, visualized using Nikon TE-2000U inverted microscope (Nikon Corporation, Tokyo, Japan), and combined with good cell survival (Ͼ85%), as determined by trypan blue exclusion. Cells were resuspended in 2 mL of DMEM (including 10% fetal calf serum, 1% 100ϫ HEPES, but no antibiotics) and seeded in 6-well cell culture plates (Corning Incorporated, Corning, NY). Nonattached cells were removed after a 24-hr incubation period and cells were stimulated with 8 M Camptothecin (Sigma, St. Louis, MO) for 5 hrs at 37°C and 5% CO 2 to activate caspase-3.
LA-4 mouse pulmonary epithelial cells (American Type Culture Collection) were grown in Falcon tissue culture flasks until approximately 90% confluence in FK-12 medium supplemented with 10% fetal calf serum, 0.01% Gentamicin, and 1% HEPES-buffered solution. Cells were then resuspended in 5 mL FK-12 (including 10% fetal calf serum, 1% 100ϫ HEPES, but no Gentamicin). Cells were divided into 2-mL tubes (Eppendorf) at a concentration of 3.0 ϫ 10 6 cells/tube, centrifuged, and resuspended in 100 L Nucleofector solution V containing either 300 pmol caspase-3 silencing RNA sequences or GFP-siRNA serv-ing as a control. Transfection protocol T-20 was chosen. Cells were then treated similarly to RAW cells as described.
Quantification of Caspase-3/18s-Ribosomal mRNA In Vitro and Ex Vivo Using Quantitative Real-Time Polymerase Chain Reaction. RNA was isolated from RAW cells or lung tissue using TriPure Isolation Reagent (Boehringer, Mannheim, Germany) as described previously (11) . Complementary DNA was synthesized using iScript cDNA Synthesis Kit (BioRad, Hercules, CA) as described previously (11) . Primer sequences for caspase-3 (forward: 5Ј-TGGAGGCTGACTTCCTGTAT-GCTT-3Ј; reverse: 5Ј-ACGGGATCTGTTTCTTT-GCGTGG-3Ј) and 18s ribosomal RNA (forward: 5Ј-GGACACGGACAGGATTGACAGATT-3Ј; reverse: 5Ј-AATCGCTCCACCAACTAAGAACGG-3Ј) were assembled by IDT (Coralville, IA).
Complementary DNA and forward and reverse primers (150 nM final concentration) in 25 L of SYBR Green quantitative polymerase chain reaction Master Mix including ROX at a concentration of 1:810 as reference dye (all Stratagene, LA Jolla, CA) were placed into plates and run in a Mx3000P real-Timepolymerase chain reaction System (Stratagene). All samples were performed in duplicate. The data were analyzed with the appropriate software (Stratagene).
Caspase-3 Activity Assay In Vitro. Caspase-3 activity in RAW 264.1 cells was assessed as described previously (11) with minor modifications. Lysed cells were added to 50 L of caspase-3 reaction buffer (containing 100 mM HEPES, 2% sucrose, 0.2% CHAPS, 10 mM Dithiothreitol; all Sigma) and 100 M Ac-DEVD 7-amino-4-trifluoromethyl-coumarin (AFC) fluorogenic substrate (Biomol, Plymouth Meeting, PA) was added to the samples. Extinction was read at 400 nm excitation and 505 nm emission on a microplate fluorescence reader (FLx800; Bio-Tek Instruments, Winooski, VT). Values were calculated against an AFC standard curve (Biomol) as M cleavage of AFC/minute/g total cell protein.
Animals. Male inbred C3H/HeN mice (Charles River Laboratories Inc., Wilmington, MA) were used. Experiments are in accordance with National Institutes of Health guidelines and are approved by the local Animal Use Committee.
ALI. ALI was induced as described previously (11, 12, 15) . Mice were anesthetized with isoflurane and catheters were inserted into both femoral arteries. Anesthesia was discontinued and blood pressure was continuously monitored through one catheter attached to a blood pressure analyzer (BPA MicroMed, Louisville, KY). When fully awake, mice were bled over a 5-to 10-min period to a mean blood pressure of 30 (Ϯ5 mm Hg) and were kept stable for 90 mins. Immediately after hemorrhage, mice were resuscitated via the catheters with Ringer's lactate at four-times the drawn blood volume. Sham-operated controls had their femoral arteries ligated and were restrained for periods of time equal to that of their hemorrhaged counterparts. Polymicrobial sepsis as produced by cecal ligation and puncture was induced 24 hrs after hemorrhage as described previously (11, 12, 15) . Mice were anesthetized with isoflurane and a 1-cm midline incision was made below the diaphragm to expose the cecum. The cecum was ligated, punctured twice with a 22-gauge needle, and gently compressed. The incision was closed in layers with 6 -0 Ethilon suture (Ethicon, Somerville, NJ). The animals were then resuscitated with 0.8 mL of lactated Ringer's solution. In sham-operated controls, laparotomy was performed in a similar fashion but the cecum was neither ligated nor punctured. These sham procedures still represent an insult sufficient to stimulate a minor inflammatory response.
Intratracheal Instillation. Intratracheal delivery of siRNA was performed as described previously (11, 12) . Thirty minutes after resuscitation, mice were anesthetized with isoflurane and their heads were reclined. The tongues were pulled out gently and siRNA or placebo was administered in the oral cavity. Mice were maintained in the described position until aspiration was complete.
Experimental Groups and Sample Acquisition for In Vivo Experiments. Mice were subjected to hemorrhagic shock, received a single intratracheal instillation of 75 g of caspase-3 siRNA or control-GFP-siRNA 30 mins thereafter, and polymicrobial sepsis 24 hrs after hemorrhage followed. Blood and lungs were harvested 12 or 24 hrs after the induction of sepsis. Lungs were gently flushed with 2 mL ice-cold phosphate-buffered saline via the right ventricle. Plasma was obtained by centrifugation of blood for 10 mins, 10,000ϫg at 4°C and frozen at Ϫ80°C until analysis. Lung lobes were excised, frozen immediately into liquid nitrogen, and stored at Ϫ80°C. For survival, animals were subjected to hemorrhagic shock (HEM) ϩ sepsis, and survival was assessed for the next 10 days on a daily basis (n ϭ 20/group).
In a second set of experiments (n ϭ 4 animals/group) with identical procedures and time points, lungs were instilled in vivo with 30 L/g body weight of 10% buffered formaldehyde after exsanguination, excised, and stored for 24 hrs in 10% formaldehyde. Afterward, lungs were paraffin-embedded and cut into 5-m sections for immunohistochemistry or hematoxylin and eosin staining.
In a third set of experiments, mice received 0.5 mg of fluorescently labeled (Alexa Fluor 488) albumin from bovine serum (Molecular Probes, Invitrogen Carlsbad, CA) 30 mins before exsanguination. Mice were killed 12 hrs after cecal ligation and puncture. Lungs were gently flushed with 10 mL ice-cold phosphatebuffered saline through the vascular system via the right ventricle, harvested, and immediately homogenized in 1 mL of ice cold phosphate-buffered saline and centrifuged. Supernatants were read at 480 nm on a fluorometric plate reader (FLx800; Bio-Tek Instruments, Winooski, VT), and readings were calculated against a standard curve of bovine serum albumin-AF488 diluted in phosphate-buffered saline and normalized per g lung protein.
Results are expressed as a lung-to-plasma ratio of bovine serum albumin-AF488.
Preparation of Tissue Samples for Cytokine Measurements. Preparation of lung homogenates for cytokine measurements was performed as described previously (11, 12) .
Protein Assay. The total amount of protein was quantified using the Bradford dye binding procedure as described previously (12) .
Chemokine Enzyme-Linked Immunosorbent Assays. Mouse keratinocyte-derived chemokine and macrophage inflammatory protein (MIP)-2 concentrations in plasma, lung tissue homogenates, bronchoalveolar lavage fluid and cell supernatants were determined using murine anticytokine antibody pairs and cytokine standards (both R&D Systems, Minneapolis, MN) as per the manufacture's protocol for basic sandwich enzyme-linked immunosorbent assay. Monocyte chemoattractant protein (MCP)-1 in cell supernatants was analyzed using mouse MCP-1 BD OptEIA enzyme-linked immunosorbent assay (BD Biosciences).
Cytometric Bead Array. Mouse tumor necrosis factor-␣, interleukin-6, interferon-␥, and MCP-1 levels were established in plasma and lung tissue homogenates using the cytometric bead array technique (BD Cytometric Bead Array Mouse Inflammation Kit, BD Biosciences) as described previously 11;12 .
Myeloperoxidase Activity. Lung myeloperoxidase activity was quantified as described previously (11, 12) .
Active Caspase-3 and ␤-Actin Western Blotting. Active caspase-3 and ␤-actin were quantified in lung tissue and cell supernatants via Western blotting as described previously (12) ; 80 g of homogenized lung tissue or cells were electrophoresed on a 18% Tris-Glycine Gel (Invitrogen) and transferred onto a polyvinylidene-difluorid membrane (Amersham, Piscataway, NJ). Membranes were incubated with polyclonal rabbit antimouse cleaved caspase-3 (Asp175) antibody (Cell Signaling) at a concentration of 1:500 at 4°C overnight. Cleaved caspase-3 (Asp175) antibody detects endogenous levels of the large fragment (17/19 kDa) of activated caspase-3 resulting from cleavage adjacent to Asp175. Membranes were incubated with ECL rabbit IgG, horseradish peroxidase-linked whole antibody from donkey (Amersham) at a concentration 1:10,000 for 1 hr and developed using enhanced chemiluminescence technique (ChemiGlow; Alpha Innotech, San Leandro, CA). Membranes were incubated with polyclonal rabbit antimouse ␤-actin (Abcam, Cambridge, MA) at a concentration of 1:10,000 and developed as described. Protein expression was quantified via densitometry using FluorChem version 4.1.0 (Alpha Innotech) and expressed as the ratio of the integrated density values of caspase-3 and ␤-actin.
Active Caspase-3 Immunohistochemistry. Active caspase-3 immunohistochemistry was performed as described previously (11, 12) .
M-30 Immunostaining. M-30 is a neoepitope that is revealed when the intermediate filament protein cytokeratin-18 on epithelial cells is cleaved by caspase-3/caspase-6/ caspase-9 at Asp396 (16), thus indicating epithelial cell-specific apoptosis. M-30 immunostaining was performed as described previously (11, 12) .
TUNEL. Quantification of TUNEL-positive cells was performed as described previously (12) using the in situ cell death detection kit (Fluorescin; Boehringer, Mannheim, Germany).
Slides for immunohistochemistry were examined as follows. Ten high-power fields (25 m 2 /field) per slide were randomly selected and counted in a blinded fashion (by CSC), and the number of fluorescent cells per highpower field was recorded for statistical analysis. Negative controls were performed by following the exact same protocols but omitting either the first or the second antibody.
Lung Hematoxylin and Eosin. Hematoxylin and eosin-stained tissue slides were histopathologically analyzed according to the following criteria as described previously (11, 12) . Distension of alveoli, thickening of alveolar septa, perivascular and peribronchial edema, and intraalveolar cellular infiltrates. Staining (Core Research Facilities, Providence, RI) and analysis (CSC) of hematoxylin and eosin-stained sections were performed by a blinded observer.
Statistical Analysis. Results are presented as mean Ϯ SEM. The Kolmogorov-Smirnov test (SigmaStat 3.0; SPSS, Chicago, IL) was used to assess normal distribution of data before performing any given statistical tests. Oneway or two-way analysis of variance followed by the Student-Newman-Keuls test as a post hoc test for multiple comparisons were performed to determine significant differences between experimental means or medians. Differences in survival were assessed using Kaplan-Meier, followed by log-rank test. A p Ͻ .05 was considered statistically significant.
RESULTS

Evaluation of Caspase-3-siRNA Sequences
The expression level of caspase-3 mRNA in RAW 264.1 cells being transfected with control siRNA after camptothecin stimulation was set to 100% for comparative purposes. Transfection with all of the caspase-3-siRNA duplexes assessed resulted in a significant knockdown of caspase-3 mRNA (duplex 1, knock-down of 94%; duplex 2, 95%; duplex 3, 97%; duplex 4, 96%) in camptothecin-activated RAW cells when com-pared to nonsense siRNA. On a protein level, caspase-3 activity (M cleaved substrate/ng protein/min) in control siRNAtransfected RAW cells was markedly elevated (mean Ϯ SEM, 66.9 Ϯ 3.5) after camptothecin stimulation when compared to unstimulated control siRNAtransfected RAW cells (31.6 Ϯ 0.3). All caspase-3-siRNA duplexes (duplex 1, 38.7 Ϯ 1.7; duplex 2, 41.7 Ϯ 1.6; duplex 3, 45.4 Ϯ 0.1; duplex 4, 43.4 Ϯ 1.7) substantially decreased caspase-3 activity when compared to control siRNA-transfected cells (66.9 Ϯ 3.5). Duplex 2 was then chosen for use in the subsequent in vivo studies. Of note, the transfection process itself did not enhance caspase-3 mRNA or caspase-3 activity. In addition, caspase-3-siRNA was also tested on LA-4 mouse epithelial cells. LA-4 cells stimulated with camptothecin and transfected with caspase-3-siRNA (mean Ϯ SEM, 1.28 Ϯ 0.25) showed markedly less active caspase-3 protein when compared to cells transfected with GFP-siRNA (3.31 Ϯ 0.63). Cells not transfected (4.22 Ϯ 2.21) did not differ significantly from cells being transfected with phosphate-buffered saline (6.8 Ϯ 3.05) or GFP-siRNA.
In Vivo Silencing of Caspase-3 Markedly Decreases Lung Apoptosis After HEM and Sepsis
Lung caspase-3 mRNA was substantially increased at 12 and 24 hrs in response to HEM ϩ sepsis in animals having received control siRNA. Caspase-3 mRNA levels were markedly decreased in animals being treated with caspase-3-siRNA when compared to control siRNAtreated animals (Fig. 1A) . On a protein level, lung active caspase-3 was also significantly enhanced at 12 hrs after the insult, and caspase-3 silencing markedly reduced lung caspase-3 activation after HEM ϩ sepsis (Fig. 1B) . The number of active caspase-3-positive cells in the lung was also increased at 12 hrs after HEM ϩ sepsis in control siRNA-treated animals (Fig. 2A2 ) when compared to sham ( Fig.  2A1 ) and decreased in HEM ϩ sepsis mice that received caspase-3 siRNA (Fig.  2A3 ). Furthermore, M-30 staining of the lungs showed substantial epithelial cell apoptosis at 12 hrs after HEM ϩ sepsis when animals received control siRNA (Fig. 2B2 ) when compared to sham (Fig.  2B1 ). After caspase-3 silencing, lung epithelial cells were markedly protected from caspase-dependent programmed cell death (Fig. 2B3 ). This was further confirmed by assessing the number of TUNEL-positive cells per high power field, which were markedly increased at 12 and 24 hrs in response to the insult in control siRNA-treated mice and substantially decreased after caspase-3 silencing (Fig. 3 ).
In Vivo Silencing of Caspase-3 Markedly Decreases Lung Inflammation After HEM and Sepsis
Lung tumor necrosis factor-␣ ( Fig.  4A ) and interleukin-6 ( Fig. 4B ) levels were substantially increased at 12 hrs after HEM ϩ sepsis in both control siRNA and caspase-3 siRNA-treated animals when compared to sham controls. However, tumor necrosis factor-␣ ( Fig. 4A ) and interleukin-6 ( Fig. 4B ) concentrations were markedly lower in caspase-3 siRNA-treated mice when compared to control siRNA-treated mice. Interestingly, lung keratinocyte-derived chemokine ( Fig. 4C ), MCP-1 (Fig. 4D) , and MIP-2 (Fig. 4E) were also substantially increased in both groups at 12 hrs and at 24 hrs after the insult. Whereas no differences between caspase-3 siRNA-treated and control siRNA-treated animals were observed here at the early 12-hr time point, lung KC, but not lung MCP-1 or MIP-2, was markedly decreased in response to caspase-3 silencing at 24 hrs after HEM ϩ sepsis. Lung interferon-␥ concentrations were not markedly different between experimental groups (data not shown).
In Vivo Silencing of Caspase-3 Markedly Decreases Systemic Inflammation After HEM and Sepsis
Plasma tumor necrosis factor-␣ (Fig.  5A) , interleukin-6 ( Fig. 5B) , KC (Fig. 5C ), MCP-1 (Fig. 5D ), and MIP-2 (Fig. 5E ) concentrations were all substantially increased at 12 and 24 hrs after HEM ϩ sepsis when compared to sham animals. At 12 hrs after the insult, plasma KC and MIP-2 did not show marked differences between caspase-3 siRNA-treated and control siRNA-treated animals; however, plasma MCP-1, tumor necrosis factor-␣, interleukin-6, and interferon-␥ levels were significantly reduced after caspase-3 silencing. Plasma MIP-2 was also mark- edly decreased at 24 hrs in double-hit animals after silencing of caspase-3 when compared to mice having received control siRNA. Plasma interferon-␥ concentrations were not markedly different between experimental groups (data not shown).
In Vivo Silencing of Caspase-3 Markedly Ameliorates Hemorrhage-Induced Septic Acute Lung Injury
Lung vascular leak was markedly increased at 12 hrs after HEM ϩ sepsis when animals had received control siRNA (Fig. 6A ). After caspase-3 silencing, lung protein leak was substantially mitigated when compared to control siRNA animals (Fig. 6A ). In addition, lung myeloperoxidase activity (Fig. 6B) was substantially enhanced at 12 and 24 hrs in response to HEM ϩ sepsis in animals having received control siRNA and was markedly abrogated after caspase-3 silencing.
Hematoxylin and eosin-prepared sections displayed lung congestion, disrupted alveolar architecture, and increased numbers of neutrophils within the alveolar walls in control siRNAtreated animals 12 hrs after HEM ϩ sepsis ( Fig. 7B ) when compared to sham (Fig. 7A ). After caspase-3 siRNA treatment, mice showed a marked protection of lung morphology after the insult (Fig. 7C ).
In Vivo Silencing of Caspase-3 Markedly Improves Survival After HEM and Sepsis
After caspase-3-siRNA treatment, 10day survival was markedly improved after HEM ϩ sepsis when compared to control siRNA-treated animals (Fig. 8 ).
DISCUSSION
Here we have investigated whether inhibition of apoptosis of lung epithelial cells can be exploited therapeutically during the development of indirect ALI. Thus far, a considerable body of literature describes pulmonary apoptosis in different types of ALI (13, (17) (18) (19) (20) . In this regard, during ALI, an increased concentration of the Fas death receptor and its ligand in patients' bronchoalveolar fluid and lung tissue have been detected (21, 22) , particularly in the acute phase of septic ARDS (23) . Furthermore, ARDS nonsurvivors exhibited markedly higher FasL concentrations when compared to survivors (24) . However, it remains far less clear whether apoptosis in the lung during indirect ALI has any pathologic mechanistic significance. In this regard, blocking of the Fas-FasL system reduced the sequelae of endotoxin-mediated experimental ALI (25) , and Fas-deficient mice even showed protection in hemorrhage-induced septic ALI (12) . Fas-FasL deficiency was also associated with a reduction in the degree of ALI seen after infection (26, 27) . However, there are limitations to the use of knockout or mutant animals, and part of the effects seen might be codependent on the absence of the Fas receptor in organs other than the lung. Previous studies have indicated that silencing of specific genes in the lungs under pathologic conditions was feasible (11, 28, 29) . Furthermore, naked double-stranded siRNA appears to localize primarily in lung epithelial cells without causing a marked inflammatory response (11) .
In our setting, lung apoptosis, as evidenced by the presence of active caspase-3 and double-strand DNA breaks, was detected as early as 12 hrs after the insult. Immunohistochemistry of caspase-cleaved cytokeratin indicated that lung epithelial cells were the primary cell type to undergo apoptosis here, which is very much in line with recent clinical findings reporting increased caspase-cleaved cytokeratin-18 concentrations in bronchoalveolar lavage fluid of ARDS patients (22) . Lung fibroblasts do not seem to be very susceptible to Fas-induced apoptosis (30) . The fact that local siRNA delivery into the lung is particularly well-suited to affect epithelial cells is supported by recent literature (31, 32) . Silencing of caspase-3 markedly reduced lung apoptosis, even when siRNA was instilled after the resuscitation period of HEM. The presence of TUNEL-positive cells after HEM ϩ sepsis, although markedly reduced after caspase-3 siRNA treatment, despite caspase-3 silencing does not preclude that alternative apoptotic pathways might also be activated by the insult. Interestingly, caspase-3 silencing not only abrogated lung apoptosis but also mitigated lung inflammation. In this regard, the fact that apoptotic pathway molecules, particularly of the extrinsic pathway, are involved in the generation of inflammatory mediators has been described previously (33) . Faouzi et al (34) observed that activation of Fas in mice in vivo-induced apoptosis as well as inflammation and blockade of caspase-3 markedly diminished activator protein-1 and hepatic chemokine production. After ischemia and reperfusion, inhibition of caspases markedly abrogated not only renal apoptosis but also inflammation and tissue injury (35) . In addition, using a broad-spectrum caspase inhibitor in bleomycin induced pneumopathy, and a substantial decrease of lung apoptosis, and pulmonary inflammation was observed (36) . The findings of Matute-Bello's group as well as our own results indicated that it might be the lung epithelial cell, which upon Fas activation, is responsible for apoptotic lung damage as well as the release of certain inflammatory mediators (12, 37) . In addition, it appears that by down regulating the local inflammatory response in the lung, this partly translated into a change in the systemic compartment. Whether this might indicate that the lung was able to function as a motor of the systemic inflammatory response after ALI and why this was not observed for all cytokines and chemokines remains to be elucidated. Interestingly, we also observed a reduction of neutrophil sequestration into the lung, evidenced by decreased lung myeloperoxidase activity, in response to caspase-3 silencing. In this regard, it is well-known that granulocytes can contribute to ALI, even in our model (15) , and inhibition of polymorphonu-clear leukocyte migration or activation has previously been shown to ameliorate hemorrhage-induced ALI (28) . Clinically, increased recruitment of neutrophils into the bronchoalveolar fluid of ARDS patients correlated significantly with a local increase in chemokines/cytokines as well as soluble Fas (22) . Thus, decreased recruitment of activated polymorphonuclear leukocytes into the lungs might have also contributed to the beneficial effects on ALI seen in our experiments.
Most interestingly, the reduction of lung apoptosis and inflammation through caspase-3 silencing and its sequelae had beneficial impact on the degree of lung injury seen in response to HEM ϩ sepsis, as evidenced by reduced capillary leak and improved lung histology. This clearly suggests a pathomechanistic role of lung apoptosis during hemorrhage-induced septic ALI. Furthermore, the fact that the reduction of lung injury was associated with an improved survival of the animals supports the concept that the lung is a major player in orchestrating/initiating multiple-organ failure during sepsis and/or trauma. The survival rate of non-siRNA-treated animals has been shown to be comparable to that of control siRNA-treated mice (12, 15) .
The fact that a single intratracheal instillation of antiapoptotic siRNA during the onset of ALI was sufficient to beneficially impact the pathologic consequences of hemorrhage-induced septic ALI is also worth mentioning. Phase I intranasal trials with siRNA targeting the viral nucleocapsid gene of the respiratory syncytial virus have already been performed (38, 39) . Based on this, phase II clinical studies designed to evaluate the safety, tolerability, and antiviral activity of this siRNA have now been initiated (40) and the potential for local delivery of siRNAs to the lung for the treatment of diverse respiratory diseases, including asthma, chronic obstructive pulmonary disease, and viral infections, is now being considered (41) .
In summary, we provide evidence here that apoptosis of lung epithelial cells is a pathophysiologically significant event in a clinically relevant double-hit model of indirect ALI. Furthermore, via an approach involving in vivo gene silencing by the deposition of siRNA against caspase-3 into the lungs, not only were several hallmarks of ALI, i.e., lung apoptosis, pulmonary inflammation, and neutrophil recruitment markedly suppressed but also an increase in survival rate of the animals was observed. Together, these data suggest that local siRNA delivery to the lungs holds considerable promise as an antiapoptotic/antiinflammatory therapeutic approach in the clinical setting of acute lung injury in humans. 
